Strides Pharma Science Ltd.

Financial

	Strides Pharma Scien	Orchid Pharma	Unichem Lab
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	260.0 .	n/a	41.0 .
Number of ANDA's Approved By USFDA	245.0 .	n/a	27.0 .
R&D as a % of Total Sales	1.82 %	n/a	7.38 %
Financials
5 yr Average ROE	-4.18 %	-4.13 %	-2.21 %
5yr average Equity Multiplier	2.64	1.73	1.28
5yr Average Asset Turnover Ratio	0.54	0.45	0.42
5yr Avg Net Profit Margin	-2.56 %	-7.02 %	-3.85 %
Price to Book	2.79	5.95	2.11
P/E	23.54	61.22	0.0
5yr Avg Cash Conversion Cycle	-66.38 Days	49.12 Days	80.33 Days
Inventory Days	69.16 Days	112.59 Days	146.44 Days
Days Receivable	71.28 Days	91.49 Days	128.35 Days
Days Payable	248.23 Days	201.52 Days	225.53 Days
5yr Average Interest Coverage Ratio	0.41	-0.51	-0.08
5yr Avg ROCE	9.77 %	0.51 %	-0.47 %
5yr Avg Operating Profit Margin	13.1 %	10.69 %	2.2 %
5 yr average Debt to Equity	1.02	0.49	0.09
5yr CAGR Net Profit	n/a	n/a	3.21 %
5yr Average Return on Assets	-1.34 %	-1.77 %	-1.68 %
Shareholdings
Promoter Holding	26.82 %	69.84 %	70.22 %
Share Pledged by Promoters	54.25 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.78 %	-20.16 %	19.29 %
Change in Mutual Fund Holding (3 Yrs)	-3.98 %	15.01 %	2.02 %

Business

	Strides Pharma Scien	Orchid Pharma	Unichem Lab
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Sterile 0 Oral Formulations 0 Bulk Drugs and chemicals 0 Formulations 0	Product Wise Break-Up Sterile 23.58 Oral Formulations 76.42 Formulations 0 Bulk Drugs and chemicals 0 Pharmaceutical 0	Product Wise Break-Up Sterile 0 Oral Formulations 0 Formulations 91.7 Bulk Chemicals 8.3 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up North America 53.01 Europe 22.7 Africa 9.64 Australia 9.16 India 0.82 Asia Pacific 0.43 USA 0 Others 4.24	Location Wise Break-Up USA 0 North America 0 Asia Pacific 0 India 18.32 Australia 0 Europe 0 Africa 0 Others 81.68	Location Wise Break-Up USA 60.68 North America 0 Asia Pacific 0 India 2.47 Australia 0 Europe 0 Africa 0 Others 36.85
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 10.0 Institutional Business 0 Others 7.0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 50.61 North America 25.41 Asia ex India 11.61 Europe 7.55 Africa 4.72 Australia 0.1	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65	-	-